Separation of terpenes and oxygenated compounds from citrus oil by supercritical CO_2 extraction

以冷榨柑橘精油为原料,采用gC/MS对柑橘精油原料进行定性及定量分析,确定了柑橘精油中的7种萜烯类化合物成分作为分离考察对象。实验探讨了超临界萃取压力、萃取温度、萃取时间和CO2流量等因素对含氧化合物分离效果的影响。实验结果表明,萃取相中萜烯类化合物的回收率总体上随着萃取压力、温度、时间和CO2流量的增大而增大。当萃取压力为12MPA,萃取温度为45℃,萃取时间为4H以及CO2流量为1.0l/MIn时,分离效果最佳,其萃取相中萜烯类化合物的回收率高达90.03%。Supercritical CO2 extraction was employed to separate terpenes and oxygenated compounds from citrus oil.The raw oil,the extract,and the raffinate were qualitatively and quantitatively analyzed by GC/MS,respectively,with the terpenes being represented by seven typical compounds.The influences of several experimental factors including extration pressure,extraction temperature,extraction time and CO2 flow rate on the separation of the oxygenated compounds were studied.The results indicate that the recovery rate of terpenes in the extract generally increases with the increasing of extraction pressure,temperature,time and CO2 flow rate.The optimum conditions for extracting terpenes are as follows: pressure 12 MPa,temperature 45 ℃,extraction time 4 h,and CO2 flow rate 1.0 L/min.Under these optimum conditions,the recovery rate of terpenes in the extract is 90.03%.福建省新世纪人才支持项目(0000-X04157

海洋浮游生物电子传递系统研究进展

国家自然科学基金!49636220;4977630

Separation and identification of auraptene from grapefruit peel oil

橙油素是广泛存在于柑橘类果实中的天然抗癌活性成分。选用SP70大孔吸附树脂分离纯化葡萄柚精油中的橙油素,该树脂对于橙油素的吸附容量和解吸率分别达到14.53 Mg/g和83.32%,并成功地从树脂床层的洗脱液中结晶分离出橙油素晶体。对所得晶体分别采用差示扫描量热仪(dSC)、紫外吸收光谱(uV)、红外吸收光谱(Ir)、电喷雾质谱(ESI-MS)进行定性分析,分析结果与橙油素标准品相符合。进一步采用高效液相色谱(HPlC)对所得晶体进行定量分析,结果表明所得晶体中橙油素的质量分数可达85%。Auraptene exists widely in the peels and juice sacs of citrus species and is reported to be an effective inhibitor of chemical carcinogenesis in some rodent models.The separation and purification of auraptene from the grapefruit peel oil was performed by SP70 macroporous resin adsorption.The amount adsorbed and the recovery of auraptene were 14.53 mg/g and 83.32% respectively.Auraptene was crystallized out from the concentrated eluate of macroporous resin bed successfully.Differential scanning calorimetric(DSC),ultraviolet spectrum(UV),infrared spectroscopy(IR) and electrospray ionization mass spectroscopy(ESI-MS) were all used to analyze the obtained crystals qualitatively.The analytical results are in accordance with that of auraptene standard.Furthermore,high performance liquid chromatography(HPLC) was utilized to quantify auraptene of the crystals obtained.The mass fraction of auraptene in the obtained crystals can reach 85%.福建省新世纪人才支持项目(0000-X04157

ENERGY BUDGETS OF HALIOTIS DIVERSCICOLOR AQUATILIS FED BY GRACILARIACEAE LICHENIODES AND FORMULA FEED

通过投喂江蓠 (Gracilariaceaelicheniodes)和配合饵料对九孔鲍 (Haliotisdiversicoloraquatilis)的能量收支进行了比较研究 .结果表明 :两种饲料组的九孔鲍耗氧率在昼夜之间均并没有明显差异 (P >0 .0 5 ) ,九孔鲍摄食两种饵料的吸收率也没有显著差异 (P >0 .0 5 ) ,而饵料系数、蛋白质效率、总生长效率则有显著的差异 (P 0 .0 5 ) .因壳能很少 ,在测定中可以忽略 .配合饵料组的软体部生长能显著高于江篱组的 (P <0 .0 5 ) .摄食江蓠和配合饵料的九孔鲍能量收支方程分别为 :江蓠组10 0C =(12 .76± 1.2 2 )F +(76 .4 7± 5 .33)R +(2 .74± 0 .4 0 )U +(6 .75± 0 .4 6 )M +(2 .78± 0 .4 8)Pg+(0 .0 3±0 .0 1)Psh- (1.5 3±... 【英文摘要】 The energy budgets of Haliotis diverscicolor aquatilis fed by Gracilariaceae licheniodes and formula feed were studied in this paper. There was no significantly different diurnal oxygen consumption rate of H. diversicolor aquatilis between the two groups (P>0.05). The absorption efficiency of the two feeds groups was not significantly different (P>0.05), while the feed coefficient,protein efficiency ratio,gross growth efficiency were significantly different (P<0.05). Although the excretion energy of the for...福建省自然科学基金项目(B0110035)资助~

改革开放:中国电影的艺术成就与文化表达

钟大丰在市场化进程中探索中国电影学院的追求回顾我们改革开放四十年,从中国的范围来讲,是一个不断走向商品市场开放的过程。电影的发展和市场开放的进程有着特别紧密的关系,当我们跟改革开放的总体进程结合得比较紧的时候,我们会看到电影表现出活力;当我们离开改革开放进程相对比较远的时候,它的活力就会减少,问题就会出现,改革开放这四十年并不一直是一帆风顺的。很多人对80年代的活跃局面很怀念,那个时

Y型聚乙二醇干扰素琢-2b注射液治疗HCV基因2/3型慢性丙型肝炎患者疗效和安全性的多中心随机对照试验研究

目的以标准剂量的聚乙二醇干扰素(Peg IFN)α-2a联合利巴韦林作为阳性对照,评价新型试验药物Y型Peg IFNα-2b注射液联合利巴韦林治疗2型/3型慢性丙型肝炎(CHC)患者的疗效和安全性。方法采用多中心、随机开放、阳性药对照的Ⅲ期临床试验,筛选符合要求的2型/3型CHC患者,按照2:1的比例随机分配到Y型Peg IFNα-2b组和Peg IFNα-2a组,同时口服利巴韦林,疗程24 w,停药随访24 w。采用Abbott Real Time HCV Genotype II检测HCV基因型,采用Cobas Taq Man实时定量PCR法检测血清HCV RNA水平。详细记录不良事件。主要疗效指标为持续病毒学应答(SVR),并进行非劣效检验。结果本试验实际入组2型/3型CHC患者255例,实际治疗241例。全分析集(FAS)数据显示,158例试验组和83例对照组患者SVR分别为85.4%(95%CI 79.94%~90.94%)和79.5%(95%CI 70.84%~88.20%,P=0.2402);对符合方案分析集(PPS)人群分析显示,试验组和对照组患者SVR分别为87.9%(95%CI 82.45%~93.27%)和85.9%(95%CI 77.82%~94.01%,P=0.7060),率差的95%可置信区间均符合非劣效标准;对PPS人群分析显示,85.8%受试者获得了早期病毒学应答(RVR),RVR的阳性预测值为90.1%;试验组和对照组不良事件发生率相似,分别为95.6%和95.2%,严重不良事件发生率分别为3.8%和3.6%。结论应用Peg IFNα联合利巴韦林治疗2型/3型CHC患者,新型试验药物Y型Peg IFNα-2b具有与对照药物Peg IFNα-2a相似的疗效和安全性。国家科技部“十二五”重大专项(编号:2012ZX10002-003)；“重大新药创制”十二五科技重大专项(编号:2012ZX09303019)